RGMa inhibits VEGF-induced and VEGF-independent tube formation and migration of HUAEC in vitro.
RGMa suppresses VEGF-induced angiogenesis in vivo.
Suppression of angiogenesis in RGMa may offer possible therapeutic application for pro-angiogenic conditions.